Vitamin D Testing Market Segment Overview, Analysis and Forecast 2023 to 2033

In 2023, the Vitamin D Testing market size is anticipated to be worth US$ 917.55 million. The market is predicted to develop at an 8.1% CAGR to reach US$ 1,999.35 million by 2033, according to Future Market Insights.

Vitamin D testing kits have become much more precise and useful as technology has advanced. These assays, which require only a little blood sample, are widely accessible and may accurately assess the body's vitamin D levels. Because of the development of immunoassay-based technologies that can discriminate between vitamin D2 and D3 forms, the use of Vitamin D Testing kits has expanded.

Technology has made it possible to test vitamin levels at home. With the advent of new technology, it is now possible to develop quick Vitamin D Testing that is both very reliable and simple to use at home. The combination of growing awareness of the importance of vitamin D and the availability of accurate quick vitamin D testing is largely responsible for the favourable market forecast.

Efforts by the government and the private sector to raise awareness of vitamin D deficiency are improving public understanding of vitamin D. Its nutritional benefits and utilisation of Vitamin D Testing processes are boosting the industry even further. Horlicks Women's Plus and Apollo Clinic, for example, teamed together in January 2022 to improve women's awareness of bone health.

Key Players

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • BIOMÉRIEUX
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Siemens Healthineers AG
  • DiaSorin S.p.A.
  • Beckman Coulter, Inc. (BD)
  • Tosoh Bioscience, Inc.
  • Quest Diagnostics Incorporated.

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/vitamin-d-testing-market

Key Segments:

Vitamin D Testing By Product:

  • 25-Hydroxy Vitamin D Testing
  • 1,25-Dihydroxy Vitamin D Testing

Vitamin D Testing by Indication:

  • Vitamin D Testing for Osteoporosis
  • Vitamin D Testing for Rickets
  • Vitamin D Testing for Thyroid Disorders
  • Vitamin D Testing for Vitamin D Deficiency
  • Others

Vitamin D Testing by Technology:

  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others

Vitamin D Testing by Patient:

  • Vitamin D Testing in Adult
  • Vitamin D Testing in Pediatric

Vitamin D Testing by Test Location:

  • Vitamin D Testing at Point-of-Care
  • Others

Vitamin D Testing by End-use:

  • Vitamin D Testing for Hospitals
  • Vitamin D Testing for Diagnostic Laboratories
  • Vitamin D Testing for Homecare
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more